Emanuel Raschi

University of Bologna, Italy

I am a clinical pharmacologist employed at the Alma Mater Sturiodium – University of Bologna.

As academic professor, I have more than a 10-year experience in teaching pharmacology across several degree programs (e.g., Medical Doctors, Dentists, Pharmacists, Medical Biotechnologists).

As academic researcher, I am currently involved in different clinical and regulatory tasks, including risk assessment in phase 1 studies (Institute of Neurological Sciences – Bellaria Hospital, Bologna), clinical consultancy on drug-drug interactions and medication review, clinical specialist for Kiwa on medical devices made of substances, member of Ethics Committees of the University of Bologna and the Republic of San Marino, member of Drug Formulary committee of the Republic of San Marino.

Main research interests are related to Clinical Pharmacology, Pharmacovigilance, Pharmacoepidemiology, with the global aim of translating clinical research into clinical practice for appropriate use of medicines, mainly through observational studies and systematic reviews. I have a specific expertise on drug-induced QT prolongation/proarrhythmia (PhD thesis and FP7-funded ARITMO project), drug-induced liver injury, cardio-oncology with novel anticancer drugs.

I am an ISoP member since more than 10 years, and I have spent the past 5 years in promoting the culture of pharmacovigilance, including the implementation of a standardized reproducible method to data processing and analysis of the FAERS database. I have been recently involved in the Steering Committee for the development of the READUS-PV Guidelines on disproportionality analysis. I have participated in the 2026 update of the WHO-ISoP pharmacovigilance curriculum.